Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Novavax, Inc.'s (NASDAQ:NVAX) Revenues Are Not Doing Enough For Some Investors
J.P. Morgan Maintains Novavax(NVAX.US) With Sell Rating, Raises Target Price to $9
Novavax (NVAX) Gets a Sell From J.P. Morgan
Express News | JP Morgan Maintains Underweight on Novavax, Raises Price Target to $9
Novavax Analyst Ratings
B. Riley Adjusts Price Target on Novavax to $23 From $25, Maintains Buy Rating
Express News | Novavax Inc : JP Morgan Raises Target Price to $9 From $8
Analysts Offer Insights on Healthcare Companies: Novavax (NVAX), Regulus (RGLS) and Canopy Growth (CGC)
"Layoff wave" sweeps North America! In addition to tech giants, dozens of well-known companies are also heavily cutting costs.
Due to the uncertain economic outlook, companies in the United States and Canada are constantly laying off employees.
Novavax Poised for U.S. Market Capture and Cost Efficiency Gains: A Resounding Buy Rating
Novavax (NVAX) Lags on Q2 Earnings & Sales, Cuts '24 Outlook
Novavax (NVAX) Receives a Hold From Bank of America Securities
Express News | Novavax Inc : BofA Global Research Cuts Price Objective to $17 From $18
Earnings Call: Novavax Q2 2024 Results Show Promise With Sanofi Deal
S&P rises over 2%, the best in nearly two years, with chip stocks up about 7%, Nasdaq and Chinese stocks up 2.8%, and US Treasury yields and the yen falling for three consecutive days.
The latest employment data alleviates concerns over the US economy, and US stocks rose more than 1.7%. Nvidia's stock rose more than 6%, and Tesla, Alibaba, PDD Holdings, and Tencent ADR rose more than 3%. Bullish on weight loss drug reports, Eli Lilly and Co's stock rose more than 13%, and Novo-Nordisk A/S's US stock rose nearly 8%. The 10-year US Treasury yield rose above 4%, and short-term bond yields rose by 10 basis points. Oil prices rose for the third consecutive day, gold halted its five-day decline, and digital currency had a big increase.
Novavax: Strategic Shifts and Cost-Cutting Amidst Market Uncertainty Prompt Hold Rating
Novavax, Inc. (NVAX) Q2 2024 Earnings Call Transcript
COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
Novavax Is a 'Super Volatile Stock,' Strategist Explains